First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
Authors
Keywords
-
Journal
Pediatric Rheumatology
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-08
DOI
10.1186/s12969-022-00768-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study
- (2021) Mei Sing Ong et al. Arthritis & Rheumatology
- Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
- (2021) Yukiko Kimura et al. Arthritis & Rheumatology
- Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
- (2021) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Development and initial validation of a composite disease activity score for systemic juvenile idiopathic arthritis
- (2020) Jessica Tibaldi et al. RHEUMATOLOGY
- Early treatment and il1rn snps affect response to anakinra in systemic juvenile idiopathic arthritis
- (2020) Manuela Pardeo et al. Arthritis & Rheumatology
- Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study
- (2019) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Emergent high fatality lung disease in systemic juvenile arthritis
- (2019) Vivian E Saper et al. ANNALS OF THE RHEUMATIC DISEASES
- Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors
- (2019) Grant S. Schulert et al. Arthritis & Rheumatology
- Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST)
- (2018) Peter A Nigrovic et al. Clinical Trials
- The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
- (2018) Sarah Ringold et al. Arthritis & Rheumatology
- Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus
- (2018) Alberto Martini et al. JOURNAL OF RHEUMATOLOGY
- The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
- (2017) Timothy Beukelman et al. Pediatric Rheumatology
- Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans
- (2017) Yukiko Kimura et al. Pediatric Rheumatology
- Proinflammatory Cytokine Environments Can Drive Interleukin-17 Overexpression by γ/δ T Cells in Systemic Juvenile Idiopathic Arthritis
- (2017) Christoph Kessel et al. Arthritis & Rheumatology
- Adding Canakinumab to the Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Systemic Juvenile Idiopathic Arthritis: Comment on the Article by DeWitt et al
- (2014) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- Defining Criteria for Disease Activity States in Nonsystemic Juvenile Idiopathic Arthritis Based on a Three-Variable Juvenile Arthritis Disease Activity Score
- (2014) Alessandro Consolaro et al. ARTHRITIS CARE & RESEARCH
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
- (2014) Peter A. Nigrovic Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis
- (2012) Flora Mcerlane et al. ANNALS OF THE RHEUMATIC DISEASES
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
- (2012) Yukiko Kimura et al. ARTHRITIS CARE & RESEARCH
- American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
- (2011) Carol A. Wallace et al. ARTHRITIS CARE & RESEARCH
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series
- (2010) Peter A. Nigrovic et al. ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now